May 17, 2005 10:56 ET Presents: Aortic Valve Replacement With 3rd Generation Stented Bioprosthesis

Live Broadcast: Thursday, June 9, 2005, 4pm CT, 5pm ET (21:00 UTC)

HOUSTON, TX -- (MARKET WIRE) -- May 17, 2005 -- David A. Ott, MD of the Texas Heart Institute at St. Luke's Episcopal Hospital in Houston, TX, will perform an aortic valve replacement procedure with the new Mosaic Ultra™ Bioprosthesis during a live webcast on June 9 at 4 pm CT. Drs. Denton A. Cooley and Ross M. Reul, also of the Texas Heart Institute, will moderate the live presentation, review valve selection criteria and surgical considerations, and address real-time web audience questions during the hour-long program.

Each year, over 100,000 Americans undergo valve replacement surgery. Third Generation tissue valves provide excellent hemodynamics and improved durability. These valves also allow patients to maintain the quality of life they have come to expect and to enjoy active lifestyles without the risks of anticoagulation therapy.

Dr. Ott was the first surgeon in the world to implant the new Mosaic Ultra™ bioprosthesis during a recent aortic valve replacement procedure. The sewing cuff of the Mosaic Ultra™ has been reduced, making it easier to implant in the narrow aortic root and allowing patients to potentially receive a larger valve which results in better hemodynamics and improved pressure gradients.

A highly skilled surgeon with vast experience in performing all types of cardiovascular procedures, Dr. David A. Ott is also active in teaching, holding appointments as Clinical Professor of Surgery at the University of Texas Medical School at Houston and at Baylor College of Medicine.

Dr. Ott is certified by the American Board of Surgery, the American Board of Thoracic Surgery, and the American Board of General Vascular Surgery. Having lectured in 15 countries and authored 140 articles in the surgical literature, Dr. Ott has enjoyed a national reputation in the field of cardiovascular surgery.

World-renowned cardiovascular surgeon Denton A. Cooley, MD, founded the Texas Heart Institute in 1962 for the study and treatment of diseases of the heart and blood vessels. Together with the Institute's clinical partner, St. Luke's Episcopal Hospital, for the past 14 years it has been ranked among the nation's top ten heart centers in an annual survey published by U.S. News & World Report.

This activity is supported by an unrestricted educational grant from Medtronic, Inc. (NYSE: MDT)

Visit now to view a program preview. A VNR is available at

Contact Information

  • Contact:

    Alex Fraser
    Director of Marketing - slp3D, Inc
    860-953-2900 x 214